Smart engineering strategies to future proof your system development

Wednesday, February 18 at 16:00 GMT | 17:00 CET | 11:00 EST | 08:00 PST

Join us for an in-depth session exploring the essential framework that guides life sciences and MedTech products from early scientific concept to sustained, high-volume production. We unpack the critical differences between R&D/assay development and production-ready medical projects, showing how an engineering-led approach anticipates the complexities of regulatory demands, scalability challenges, and long-term data capture.

Learn where early, strategic collaboration creates a decisive competitive advantage, and how addressing the non-obvious challenges early can mean the difference between a promising breakthrough and a reliable, profitable commercial product.

Key learning objectives:

• Recognize and adapt to the fundamental differences between scientific discovery (assay development) and product development (regulatory requirements).
• Understand how early engineering collaboration ensures the instrument development (hardware/software) supports and accelerates potential changes in the assay and data analysis.
• Identify the critical, non-obvious manufacturing and supply chain focus areas that must be addressed early to guarantee a smooth, successful product launch.
• Learn how to leverage Plexus's full-cycle expertise to transform a scientific concept into a high-quality, scalable, and commercially viable product.

Who should attend?

This event is perfect for individuals working in:

• Product & strategy management
• R&D
• Engineering & technical
• Quality & regulatory
• Assay development

Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.